Premier Fund Managers’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,400
Closed -$417K 224
2023
Q4
$417K Sell
17,400
-12,564
-42% -$281K 0.02% 168
2023
Q3
$689K Sell
29,964
-36,137
-55% -$919K 0.03% 133
2023
Q2
$1.76M Sell
66,101
-24,965
-27% -$659K 0.07% 111
2023
Q1
$2.5M Sell
91,066
-87,533
-49% -$2.31M 0.1% 113
2022
Q4
$4.07M Buy
178,599
+171,199
+2,314% +$4.77M 0.16% 109
2022
Q3
$253K Sell
7,400
-208,611
-97% -$7.71M 0.02% 161
2022
Q2
$6.27M Hold
216,011
0.28% 82
2022
Q1
$5.89M Buy
+216,011
New +$5.1M 0.21% 103

Other funds holding PRVA

Premier Fund Managers's PRVA Position: Q1 2024 in Review

Premier Fund Managers sold out of Privia Health (PRVA) in Q1 2024, closing a stake of 17,400 shares — an estimated $417K sold.

Premier Fund Managers first reported a position in PRVA in Q1 2022 and held it in 8 quarters. The position peaked at $6.27M in Q2 2022. 234 funds tracked by Wall St. Rank hold PRVA as of Q1 2024.

  • Premier Fund Managers reported no remaining Privia Health position as of Q1 2024 after selling out during the quarter.
  • Premier Fund Managers sold 17,400 Privia Health shares in Q1 2024, an estimated $417K.
  • Premier Fund Managers first reported a position in Privia Health in Q1 2022 and held it in 8 quarters.
  • Premier Fund Managers's Privia Health position peaked at $6.27M in Q2 2022.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q1 2024.

Based on Premier Fund Managers's 13F filing for Q1 2024, filed 13 May 2024.